Why BioNTech Thrashed the Market on Thursday

·2 min read
Why BioNTech Thrashed the Market on Thursday

With its latest ruling on the biotech's coronavirus vaccine, the FDA boosts the investment case for the stock.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting